article thumbnail

Top Drug Development Consulting Firms, Companies, Services, & Consultants

Jake Jorgovan

Additionally, evaluating the firm's approach to communication and collaboration is crucial. Novotech Novotech is a global full-service clinical Contract Research Organization (CRO) specializing in drug development consulting for biotech and pharmaceutical companies. What drug development consulting firm will you choose?

Biopharma 130
article thumbnail

Frost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence, Highlighting Agility, Responsiveness, Customer Value, and Proven Ability to Expedite Quality Clinical Programs

Frost & Sullivan

27 th August 2024 – Frost & Sullivan recently assessed the biotech contract research organization (CRO) industry and, based on its results, recognizes Avance Clinical with the 2024 Global Customer Value Leadership Award. SAN ANTONIO, TX. –

Biotech 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 11 Life Science Consultants & Consulting Firms

Jake Jorgovan

CSSi LifeSciences CSSi LifeSciences is a global, innovative Contract Research Organization (CRO) and consulting group specializing in advancing therapeutics and medical devices through development and regulatory approval. Collaborative Approach: Choose a firm that values collaboration and open communication.

article thumbnail

Are You Leveraging the Drug Discovery and Early Development Outsourcing Services Ecosystem to Accelerate Growth?

Frost & Sullivan

Growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) leading industry growth. Top 10 pharma companies contribute only 4-5% to R&D pipeline; top 25 contribute less than 10%.

article thumbnail

Top 10 Strategic Imperatives Driving Innovation in AI-Enhanced Drug Discovery and Development

Frost & Sullivan

This is fueling the growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) driving industry growth. Conversely, small-to-mid, and emerging biopharma players, with 1 or 2 molecules in the pipeline, contribute over 16%.

article thumbnail

AI and the Future of Clinical Trials: Accelerating Efficiency and Success Rates

Frost & Sullivan

It also facilitates collaboration between traditionally separate industries, creating new opportunities for growth and innovation. Contract research organizations (CROs) and pharmaceutical companies are using AI to refine their go-to-market strategies, improve patient recruitment, and enhance retention for decentralized trials.

article thumbnail

Redefining clinical trials: Adopting AI for speed, volume and diversity

IBM Business Partners

The rise in the deployment of electronic patient-reported outcomes (ePROs), electronic clinical outcome assessments (eCOAs), and electronic informed consent (eConsent) from 2020 to 2021, primarily driven by contract research organizations underscores this shift.